118 related articles for article (PubMed ID: 236372)
21. The metabolism of biological alkylating agents.
Jones AR
Drug Metab Rev; 1973; 2(1):71-100. PubMed ID: 4359524
[No Abstract] [Full Text] [Related]
22. [A volatile alkylating agent in the exhaled air following the administration of Endoxan].
Rauen HM; Norpoth K
Klin Wochenschr; 1968 Mar; 46(5):272-5. PubMed ID: 5697858
[No Abstract] [Full Text] [Related]
23. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
[TBL] [Abstract][Full Text] [Related]
24. The metabolism of the anti-tumour agent 1(1-aziridinyl)- 2,4-dinitrobenzene (CB 1837).
Connors TA; Hickman JA; Jarman M; Melzack DH; Ross WC
Biochem Pharmacol; 1975 Sep; 24(18):1665-70. PubMed ID: 1191326
[No Abstract] [Full Text] [Related]
25. Enzyme-induced aziridine formation by rat liver microsomes.
Hata Y; Watanabe M
Biochem Biophys Res Commun; 1983 Jan; 110(1):220-7. PubMed ID: 6838512
[TBL] [Abstract][Full Text] [Related]
26. Fragmentation reaction of ylide. 5. A new metabolic reaction of aziridine derivatives.
Hata Y; Watanabe M; Matsubara T; Touchi A
J Am Chem Soc; 1976 Sep; 98(19):6033-6. PubMed ID: 965638
[No Abstract] [Full Text] [Related]
27. Effects of ascorbic acid on biologically obtained diaziquone free radicals.
Gutierrez PL; Egorin MJ; Davis TA; Bachur NR
Biochem Pharmacol; 1985 Jul; 34(13):2394-7. PubMed ID: 2990485
[No Abstract] [Full Text] [Related]
28. [Metabolism of the antineoplastic agent N-pyrimidly-2N1, N2-di-(ethylene)-triamide phosphate (fosfemid)].
Safonova TS; Linberg LF; Presnova ZhF; Kuriatov NS; Chernov VA
Dokl Akad Nauk SSSR; 1974; 219(5):1271-2. PubMed ID: 4442341
[No Abstract] [Full Text] [Related]
29. Diaziridinylbenzoquinones.
Di Francesco AM; Ward TH; Butler J
Methods Enzymol; 2004; 382():174-93. PubMed ID: 15047102
[No Abstract] [Full Text] [Related]
30. Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069.
Workman P; Walton MI
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1307-10. PubMed ID: 6547936
[TBL] [Abstract][Full Text] [Related]
31. A correlation between cyclophosphamide induced leukopenia in mice and the presence of alkylating metabolites.
Hayes FD; Short RD; Gibson JE
Proc Soc Exp Biol Med; 1972 Feb; 139(2):417-21. PubMed ID: 5059031
[No Abstract] [Full Text] [Related]
32. Alkylboronic acids accelerate affinity labelling of acetylcholinesterase with N,N-dimethyl-2-phenylaziridinium ion.
Palumaa P; Järv J
Biochim Biophys Acta; 1984 Jan; 784(1):35-9. PubMed ID: 6691983
[TBL] [Abstract][Full Text] [Related]
33. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
[No Abstract] [Full Text] [Related]
34. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
[TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide, 2,2-dimethylaziridines and other alkylating agents as inhibitors of serum cholinesterase.
Lalka D; Bardos TJ
Biochem Pharmacol; 1975 Feb; 24(4):455-6. PubMed ID: 1167458
[No Abstract] [Full Text] [Related]
36. Selection of carriers for alkylating moieties to increase their antitumor specificity: a different aspect.
Niculescu-Duvăz I; Baracu I
Cancer Treat Rep; 1977 Aug; 61(5):929-31. PubMed ID: 890700
[No Abstract] [Full Text] [Related]
37. Electrochemistry of potential bioreductive alkylating quinones: its use in the development of new aziridinylquinones.
Driebergen RJ; Holthuis JJ; Hulshoff A; Postma-Kelder SJ; Verboom W; Reinhoudt DN; Lelieveld P
Anticancer Res; 1986; 6(4):605-19. PubMed ID: 3752941
[TBL] [Abstract][Full Text] [Related]
38. Development of a lyophilised RH1 formulation: a novel DT diaphorase activated alkylating agent.
Elliott MA; Ford SJ; Walker AA; Hargreaves RH; Halbert GW
J Pharm Pharmacol; 2002 Apr; 54(4):487-92. PubMed ID: 11999125
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of intravenous and intramuscular methohexitone in dogs.
Pinaud M; Meignier M; Kergueris MF; Le Normand Y; Lasserre MP; Souron R; Larousse C
Eur J Anaesthesiol; 1984 Mar; 1(1):55-62. PubMed ID: 6536507
[TBL] [Abstract][Full Text] [Related]
40. Physical association of two simple alkylators to some DNA sequences.
Pearlstein RA; Tripathy SK; Potenzone R; Malhotra D; Hopfinger AJ; Klopman G; Max N
Biopolymers; 1980 Feb; 19(2):311-24. PubMed ID: 7370399
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
